tiprankstipranks

Jeffrey Jonas Insider Profile

4 Followers
Jeffrey Jonas, President & CEO, Director at SAGE Therapeutics, holds 54.53K shares in SAGE Therapeutics (Ticker: SAGE), holds ― shares in Karuna Therapeutics (Ticker: KRTX), holds ― shares in Generation Bio (Ticker: GBIO). Most recently, Jeffrey Jonas Bought ― shares of SAGE Therapeutics on Dec 10, 2019 for an estimated value of 481.50K.
tipranks
Jeffrey Jonas

Jeffrey Jonas
SAGE Therapeutics (SAGE)
President & CEO, Director

Ranked #42,965 out of 78,624 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

-2.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
0.00%
0.00%
0.00%
A breakdown of Jeffrey Jonas's holdings

Insider Roles

SAGE Therapeutics
(SAGE)
President & CEO, Director
Karuna Therapeutics
(KRTX)
Director
Generation Bio
(GBIO)
Director
Ionis Pharmaceuticals
(IONS)
EVP
Roles that Jeffrey Jonas holds in companies

Most Profitable Insider Trade

Stock:
SAGE Therapeutics
(SAGE)
Rating:Informative Buy
Date:Jul 23, 2014 - Jul 23, 2015
Return:+173.30%
The most profitable trade made by Jeffrey Jonas

Jeffrey Jonas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SAGE Therapeutics
Dec 10, 2019
President & CEO, Director
Informative Buy
481.50K
$4.12M
Karuna Therapeutics
Director
Generation Bio
Director
Ionis Pharmaceuticals
EVP
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Jonas's performance on stock

Jeffrey Jonas insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Jonas?
The percentage of profitable transactions made by Jeffrey Jonas is 43%.
    What is the average return per transaction made by Jeffrey Jonas?
    The average return per transaction made by Jeffrey Jonas is -2.00%.
      What stocks does Jeffrey Jonas hold?
      Jeffrey Jonas holds: SAGE, KRTX, GBIO, IONS stocks.
        What was Jeffrey Jonas’s latest transaction?
        Jeffrey Jonas latest transaction was an Informative Buy of $481.50K.
          What was Jeffrey Jonas's most profitable transaction?
          Jeffrey Jonas’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
            What is Jeffrey Jonas's role in SAGE Therapeutics?
            Jeffrey Jonas's role in SAGE Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.